Risk factors for death from Stenotrophomonas maltophilia bacteremia
- PMID: 29673561
- DOI: 10.1016/j.jiac.2018.03.011
Risk factors for death from Stenotrophomonas maltophilia bacteremia
Abstract
Purpose: Stenotrophomonas maltophilia has low pathogenicity potential, but if it causes bacteremia it can be fatal, because it has shown high resistance to many antibiotics and can be difficult to treat. Patient death from S. maltophilia bacteremia has increased since 2014 in our hospital. In this study, we investigated risk factors for death due to S. maltophilia bacteremia.
Methods: Seventy patients from the hospital database with S. maltophilia bacteremia between January 2010 and July 2017 were investigated. We retrospectively analyzed risk factors including gender, age, wards, hospitalized duration, clinical history, devices, source of S. maltophilia identification, polymicrobial bacteremia, prior antimicrobial therapy, antimicrobial therapy after bacteremia, and resistance to antibiotics. The statistical analysis was performed to compare the period from 2010 to 2013 to from 2014 to 2017.
Results: Comparing the 2010-2013 period to the 2014-2017 period, it revealed that history of hospitalization, identification of S. maltophilia from sputum, polymicrobial bacteremia, prior carbapenem use, and mortality was significantly different in S. maltophilia bacteremia (p = 0.028, p = 0.004, p < 0.001, p = 0.034, and p = 0.007, respectively). Comparison between non-survivors and survivors for 2010-2013 and 2014-2017 found ICU admission and ventilator use were seen more often in non-survivors (p = 0.030 vs p = 0.013 and p = 0.027 vs p = 0.010, respectively).
Conclusions: Our analyses showed increase in mortality from S. maltophilia bacteremia from 2014 to 2017, and that non-survivors had a higher frequency of ICU admission and ventilator use in both the 2010-2013 and 2014-2017 periods. There were more combination antimicrobial therapy cases after bacteremia in 2014-2017. Further prospective studies with larger numbers of patients should be undertaken for definitive conclusions.
Keywords: Bacteremia; Infection control: risk factor; Stenotrophomonas maltophilia.
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.J Microbiol Immunol Infect. 2016 Jun;49(3):378-86. doi: 10.1016/j.jmii.2014.06.005. Epub 2014 Jul 28. J Microbiol Immunol Infect. 2016. PMID: 25081988
-
Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.Antimicrob Resist Infect Control. 2021 Jan 22;10(1):19. doi: 10.1186/s13756-021-00888-w. Antimicrob Resist Infect Control. 2021. PMID: 33482916 Free PMC article.
-
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):13-20. doi: 10.1007/s10096-006-0243-7. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17200840
-
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.Clin Microbiol Infect. 2019 May;25(5):546-554. doi: 10.1016/j.cmi.2018.11.008. Epub 2018 Nov 16. Clin Microbiol Infect. 2019. PMID: 30448331
-
Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis.Infect Dis (Lond). 2024 May;56(5):335-347. doi: 10.1080/23744235.2024.2324365. Epub 2024 Mar 4. Infect Dis (Lond). 2024. PMID: 38436567 Review.
Cited by
-
Clinical diagnostic value of metagenomic next-generation sequencing in patients with acute infection in emergency department.Heliyon. 2024 Aug 8;10(16):e35802. doi: 10.1016/j.heliyon.2024.e35802. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39220937 Free PMC article.
-
The 'microbiome counterattack': Insights on the soil and root-associated microbiome in diverse chickpea and lentil genotypes after an erratic rainfall event.Environ Microbiol Rep. 2023 Dec;15(6):459-483. doi: 10.1111/1758-2229.13167. Epub 2023 May 24. Environ Microbiol Rep. 2023. PMID: 37226644 Free PMC article.
-
Clinical presentation and outcomes of bloodstream infection with intrinsically carbapenem-resistant non-fermenting gram-negative organisms: Stenotrophomonas maltophilia, Elizabethkingia spp. and Chryseobacterium spp. in Singapore, from 2012 to 2024.BMC Infect Dis. 2025 Feb 25;25(1):273. doi: 10.1186/s12879-025-10636-9. BMC Infect Dis. 2025. PMID: 40000958 Free PMC article.
-
In vitro activity of ceftazidime/avibactam, cefiderocol, meropenem/vaborbactam and imipenem/relebactam against clinical strains of the Stenotrophomonas maltophilia complex.PLoS One. 2024 Apr 18;19(4):e0298577. doi: 10.1371/journal.pone.0298577. eCollection 2024. PLoS One. 2024. PMID: 38635685 Free PMC article.
-
Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant Stenotrophomonas maltophilia in a Mouse Model.Front Microbiol. 2022 Jul 5;13:906961. doi: 10.3389/fmicb.2022.906961. eCollection 2022. Front Microbiol. 2022. PMID: 35865914 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical